News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
148 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38485)
2025 (21537)
Month
January (2488)
February (2603)
March (3228)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
1 (103)
2 (1)
4 (140)
5 (169)
6 (148)
7 (144)
8 (68)
9 (22)
10 (23)
11 (209)
12 (180)
13 (124)
14 (146)
15 (82)
17 (2)
18 (146)
19 (143)
20 (110)
21 (123)
22 (70)
24 (1)
25 (2)
26 (8)
27 (78)
28 (44)
29 (45)
30 (1)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
4
5
6
7
8
9
10
11
12
13
14
15
17
18
19
20
21
22
24
25
26
27
28
29
30
Deals
Advanced Accelerator Applications Board of Directors Recommends $3.9B All Cash Tender Offer by Novartis
The transaction is subject to customary transactional regulatory approvals.
December 6, 2017
·
8 min read
Biotech Bay
Evolve BioSystems’ Activated B. infantis EVC001 Demonstrates Substantial and Persistent Remodeling of the Infant Gut Microbiome
The study showed that providing dietary B. infantis EVC001 resulted in rapid, substantial, and persistent remodeling of the gut microbiome in breastfed infants.
December 6, 2017
·
5 min read
EOS imaging Awarded the Prix Galien in the Medical Device Category
The award is presented to EOS imaging in recognition of its EOS system for 2D/3D low dose imaging and associated EOSapps suite of online 3D surgical planning solutions for spine, hip and knee surgeries.
December 6, 2017
·
2 min read
Deals
Edwards Lifescience Scoops Up Harpoon Medical for $100M
In addition, there is the potential for up to $150 million in pre-specified milestone-driven payments over the next 10 years.
December 6, 2017
·
4 min read
Business
BioDerm Awards Medline Exclusive Distribution Agreement
Starting Jan. 1, 2018, Medline will have exclusive distribution rights in the USA and Canada to Men’s Liberty Acute, a male external catheter designed especially for the acute care market as a means of avoiding Foley catheter use by men within the appropriate patient diagnosis segment.
December 6, 2017
·
3 min read
FDA
Magnair an eFlow Closed System Nebulizer Together With Sunovion’s Lonhala is the First eFlow Technology Based Product to Receive FDA Approval to Treat COPD
The drug//device combination product received FDA approval on December 5th, 2017 under a NDA.
December 6, 2017
·
3 min read
Essilor: Disclosure of Share Capital and Voting Rights Outstanding as of November 30, 2017
As of November 30, 2017, shares and voting rights outstanding of Essilor, the world leader in ophthalmic optics, broke down as follows:
December 6, 2017
·
1 min read
Genetown
Obsidian Therapeutics Announces $49.5M Million Series A Financing to Develop Controllable Cell and Gene Therapy Products
Obsidian today announced the completion of a $49.5M Series A financing to further build its technology platform and advance its lead programs toward clinical development.
December 6, 2017
·
5 min read
Tetra Bio-Pharma Opens Markets at TSX Listing Ceremony
The listing ceremony took place at the TMX Broadcast Centre in Toronto, Ontario. Bernard Fortier, Chief Executive Officer (CEO), and Bernard Lessard, Chief Financial Officer, represented Tetra at the listing ceremony.
December 6, 2017
·
5 min read
Biotech Beach
Puma Biotechnology Presents Interim Results of Phase II CONTROL Trial of Neratinib in Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancer at the 2017 San Antonio Breast Cancer Symposium
The presentation entitled, “Effects of adding budesonide or colestipol to loperamide prophylaxis on neratinib-associated diarrhea in patients with HER2-positive early stage breast cancer: the CONTROL trial,” will be presented at a poster session on December 7 at 5:00 p.m. CST.
December 6, 2017
·
11 min read
Previous
13 of 15
Next